Loading organizations...
Otsuka is a global healthcare company that develops, manufactures, and markets innovative pharmaceutical products. It focuses on addressing unmet medical needs across various therapeutic areas, utilizing scientific research and development to improve patient health. Its portfolio spans prescription medicines, medical devices, nutraceuticals, and consumer products, aiming to provide comprehensive health solutions worldwide.
The company's origins date to 1921, when Busaburo Otsuka founded Otsuka Pharmaceutical in Tokushima, Japan. Initially manufacturing chemical raw materials, Otsuka's insight was applying scientific principles to production, establishing its expansion into healthcare. His vision for a research-driven enterprise gradually prioritized drug discovery and development.
Otsuka serves a broad global customer base, including patients, healthcare providers, and consumers. Operating under the mission, "Otsuka-people creating new products for better health worldwide," the company strives to continuously develop novel products and services. Its vision is to make a meaningful impact on individual well-being globally through innovative healthcare solutions.
Key people at Otsuka.
Otsuka was founded in 2020 by Busaburo Otsuka (Founder).
Otsuka was founded in 2020 by Busaburo Otsuka (Founder).
Otsuka has 4 tracked investments across 4 companies. The latest tracked deal is $2.0M Series A in VIE STYLE in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 7, 2024 | VIE STYLE | $2.0M Series A | — | Murata Electronics, Ryojiro Yamamoto, S Nishimoto |
| Apr 1, 2020 | COMPASS Pathways | $80.0M Series B | — | Sean RAD, Able Partners, ATAI Life Sciences, Camden Partners, Peter Thiel, Perceptive Advisors, Skyviews Life Science, Soleus Capital |
| Apr 13, 2015 | ReCor Medical | $15.0M Series D | Otsuka | Sofinnova Partners |
| May 1, 2013 | Proteus Digital Health | $62.5M Series F | — | Novartis, Oracle, Sino Group |
